CompanyHealthAi
Avenue Biosciences
Avenue Biosciences is a transatlantic biotech building the first platform to measure and modulate the cellular secretory pathway at scale. Spun out of the University of Helsinki and headquartered between Helsinki and Palo Alto, the company pairs high-throughput chemistry with machine learning to design signal peptides and boost yields of therapeutic proteins - biologics, biosimilars, and mRNA-encoded medicines - so that production bottlenecks stop limiting which therapies reach patients.
2023Founded
Palo AltoHQ
$5.7MSeed Extension
biotechprotein-engineeringsynthetic-biologymachine-learningai-driven-drug-discoverybiologics